All updated as on -
The market for digital biomanufacturing is anticipated to reach a value of US$ 17.99 billion in 2022 and is projected to grow at a CAGR of 10.9% from 2023 to 2030.
Unique elements of biological activity are addressed by digital biomanufacturing, which also improves data gathering, monitoring, process control algorithms, automation, etc. Innovations in product creation, factory operations, and materials supply are all being changed by technologies like artificial intelligence (AI), automation, and robotics. Therefore, the market expansion in the near future is projected to be boosted by the rising application of smart manufacturing in bio-based sectors.
The global lockdown caused by the coronavirus (COVID-19) pandemic has had an effect on the financial health of companies in all industries. One industry that has been severely damaged by the pandemic is the private healthcare sector. As a result, the rapid uptake of digital technologies in the biopharma industry during the pandemic has increased demand for digital bioprocessing, which in turn has increased market growth.
Using digital technologies in manufacturing processes, such as computer-aided design and computer-assisted machining, is known as "digital biomanufacturing." By enhancing manufacturing cycles, the use of these technologies can assist raise quality and safety requirements while also lowering costs. With robotic automation systems like Microfluidic Devices, digital biomanufacturing enables increased precision in cell cultures or tissue engineering. It also makes it possible to remotely monitor individual units using embedded sensors that transmit data back to operators via wireless networks, enabling more effective management of inventory levels during manufacturing.
The most recent advancements in automation and analytics have been used in manufacturing facilities, and they are known as manufacturing technologies. One such instance is smart machining cells, which may be linked with a software platform to help decision-making or optimize production processes by real-time evaluating data collected from machines, sensors, and other sources. Their objective is to decrease waste while simultaneously increasing productivity through improved product quality, speed, and precision. Production of food and beverages is one industry that uses manufacturing technologies.
The digital tools used to optimize the biomanufacturing processes are analytical and process control technology. These include analytical techniques like chromatography for evaluating medication compounds in order to determine quality or purity as well as software, equipment that monitors performance parameters of a production process and sends alerts when deviations occur. These innovations contribute to higher product yields, lower prices, and higher quality. One illustration of this is the use of chromatography to examine pharmacological compounds and determine their quality or purity. This technique can be applied at numerous manufacturing stages, including raw material testing, phased development, and process control monitoring.
Report Coverage
Global Digital Biomanufacturing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Digital Biomanufacturing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Digital Biomanufacturing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Digital Biomanufacturing market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Digital Biomanufacturing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Digital Biomanufacturing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
3M Co., ABB Group, Agilent Technologies Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., Waters Corp., AB Sciex LLC, Sartorius Stedium Biotech GmbH, Alertenterprise, GE Healthcare, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Culture Biosciences.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Digital Biomanufacturing market based on the below-mentioned segments:
Global Digital Biomanufacturing Market, By Type
Manufacturing Technologies
Analytical and Process Control Technologies
Software
Others
Global Digital Biomanufacturing market, By Application
Bioprocess Optimization
Process Analytics
Biomanufacturing Process Automation
Control
Flexible Manufacturing
Others
Global Digital Biomanufacturing Market, By End User
Pharmaceutical Companies
Biotechnology Firms
Research Institutes
Contract Manufacturing Organizations
Global Digital Biomanufacturing market, Regional Analysis
Unique elements of biological activity are addressed by digital biomanufacturing, which also improves data gathering, monitoring, process control algorithms, automation, etc. Innovations in product creation, factory operations, and materials supply are all being changed by technologies like artificial intelligence (AI), automation, and robotics. Therefore, the market expansion in the near future is projected to be boosted by the rising application of smart manufacturing in bio-based sectors.
The global lockdown caused by the coronavirus (COVID-19) pandemic has had an effect on the financial health of companies in all industries. One industry that has been severely damaged by the pandemic is the private healthcare sector. As a result, the rapid uptake of digital technologies in the biopharma industry during the pandemic has increased demand for digital bioprocessing, which in turn has increased market growth.
Using digital technologies in manufacturing processes, such as computer-aided design and computer-assisted machining, is known as "digital biomanufacturing." By enhancing manufacturing cycles, the use of these technologies can assist raise quality and safety requirements while also lowering costs. With robotic automation systems like Microfluidic Devices, digital biomanufacturing enables increased precision in cell cultures or tissue engineering. It also makes it possible to remotely monitor individual units using embedded sensors that transmit data back to operators via wireless networks, enabling more effective management of inventory levels during manufacturing.
The most recent advancements in automation and analytics have been used in manufacturing facilities, and they are known as manufacturing technologies. One such instance is smart machining cells, which may be linked with a software platform to help decision-making or optimize production processes by real-time evaluating data collected from machines, sensors, and other sources. Their objective is to decrease waste while simultaneously increasing productivity through improved product quality, speed, and precision. Production of food and beverages is one industry that uses manufacturing technologies.
The digital tools used to optimize the biomanufacturing processes are analytical and process control technology. These include analytical techniques like chromatography for evaluating medication compounds in order to determine quality or purity as well as software, equipment that monitors performance parameters of a production process and sends alerts when deviations occur. These innovations contribute to higher product yields, lower prices, and higher quality. One illustration of this is the use of chromatography to examine pharmacological compounds and determine their quality or purity. This technique can be applied at numerous manufacturing stages, including raw material testing, phased development, and process control monitoring.
Report Coverage
Global Digital Biomanufacturing research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Digital Biomanufacturing report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Digital Biomanufacturing competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Digital Biomanufacturing market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | 3M Co., ABB Group, Agilent Technologies Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., Waters Corp., AB Sciex LLC, Sartorius Stedium Biotech GmbH, Alertenterprise, GE Healthcare, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Culture Biosciences. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Digital Biomanufacturing Market from 2021 to 2030.
- Market Forecast for Digital Biomanufacturing Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Digital Biomanufacturing competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Digital Biomanufacturing
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Digital Biomanufacturing market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Digital Biomanufacturing market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
3M Co., ABB Group, Agilent Technologies Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., Waters Corp., AB Sciex LLC, Sartorius Stedium Biotech GmbH, Alertenterprise, GE Healthcare, Cytiva, Siemens, immersciobio, Sanofi, BIOMÉRIEUX, Culture Biosciences.
Primary Target Market
- Market Players of Digital Biomanufacturing
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Digital Biomanufacturing market based on the below-mentioned segments:
Global Digital Biomanufacturing Market, By Type
Manufacturing Technologies
Analytical and Process Control Technologies
Software
Others
Global Digital Biomanufacturing market, By Application
Bioprocess Optimization
Process Analytics
Biomanufacturing Process Automation
Control
Flexible Manufacturing
Others
Global Digital Biomanufacturing Market, By End User
Pharmaceutical Companies
Biotechnology Firms
Research Institutes
Contract Manufacturing Organizations
Global Digital Biomanufacturing market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive digital biomanufacturing market market research and competitor analysis for your business to help you develop more profound insights into the digital biomanufacturing market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the digital biomanufacturing market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.